The majority of Americans perceive cannabis as less dangerous than alcohol, a new survey finds.
Most people in the US view cannabis as having medical purposes and believe it to have less potential for abuse than alcohol and prescription drugs.
Researchers from the University of Delaware and with Michigan State University, asked a nationally representative sample of Americans, aged 18 to over 75, about their views on cannabis and CBD.
The researchers stated: “The results show that the majority of US consumers perceive cannabis (as CBD, hemp, marijuana, and THC) as having medical uses and view the potential for abuse of cannabis as less than for commonly prescribed medications and alcohol.”
They went on to say that the findings make it clear that those in the US “would not classify any of the cannabis derivatives as Schedule I substances” and perceive them as having “no greater potential for abuse than cocaine and methamphetamine (Schedule II)”.
Among those who said they had personally used either cannabis and CBD, just under half said that they did so “as a replacement for other medications.”
Most frequently, respondents said that they replaced anti-anxiety medications and opioids with cannabinoids – a finding that is consistent with prior studies.
This is the first study to identify perceptions of cannabis for medical use and its potential for abuse, among US consumers.
It comes as five states voted to legalise medical and/or recreational cannabis in the US election in November, among calls for federal legalisation.
Under federal law, the cannabis plant is currently classified as a Schedule I controlled substance with “a high potential for abuse” and “no currently accepted use in treatment in the United States.”
Alcohol is not scheduled within the US Controlled Substances Act.
Paul Armentano, deputy director of US cannabis reform group, NORML, said that he was not surprised by the survey’s findings.
“The overwhelming majority of Americans have long abandoned the federal government’s ‘Flat Earth’ position that marijuana is a highly dangerous substance without any therapeutic efficacy,” he said on the organisation’s website.
“It is time for Congress to jettison this intellectually dishonest position as well and remove cannabis from the Controlled Substances Act in a manner similar to alcohol — thereby ending the existing state/federal conflict and permitting state governments, not the federal government, to be the primary arbiters of cannabis policy.”
- Malta gives green light to three new cannabis clubs
- European Commission must address ‘inequality’ in access to medicinal cannabis across EU
- 1 in 8 older US adults now use cannabis products, finds study
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Advocacy6 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- Industry6 months ago
New report calls for overhaul of ‘discriminatory’ UK cannabis driving laws
- News4 months ago
Malta: Advocates emphasise positive effects of cannabis reform amid ‘normalisation’ concerns
- Science4 months ago
Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure